loading
Stoke Therapeutics Inc stock is traded at $12.62, with a volume of 20,153. It is down -1.75% in the last 24 hours and up +8.37% over the past month. Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
See More
Previous Close:
$12.85
Open:
$12.52
24h Volume:
20,153
Relative Volume:
0.03
Market Cap:
$690.65M
Revenue:
$8.78M
Net Income/Loss:
$-104.70M
P/E Ratio:
-5.327
EPS:
-2.37
Net Cash Flow:
$-82.68M
1W Performance:
-3.63%
1M Performance:
+8.37%
6M Performance:
+9.97%
1Y Performance:
-14.23%
1-Day Range:
Value
$12.48
$12.65
1-Week Range:
Value
$12.25
$13.22
52-Week Range:
Value
$5.35
$16.15

Stoke Therapeutics Inc Stock (STOK) Company Profile

Name
Name
Stoke Therapeutics Inc
Name
Phone
781-430-8200
Name
Address
45 WIGGINS AVENUE, BEDFORD, MA
Name
Employee
128
Name
Twitter
@stoketx
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
STOK's Discussions on Twitter

Compare STOK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
STOK
Stoke Therapeutics Inc
12.65 702.66M 8.78M -104.70M -82.68M -2.37
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.26 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.70 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
395.81 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
663.60 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.70 32.46B 3.81B -644.79M -669.77M -6.24

Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-18-25 Initiated Jefferies Buy
Dec-20-24 Initiated Chardan Capital Markets Buy
Oct-14-24 Resumed Leerink Partners Outperform
Mar-26-24 Upgrade TD Cowen Market Perform → Outperform
Nov-20-23 Resumed JP Morgan Neutral
Jul-25-23 Downgrade TD Cowen Outperform → Market Perform
May-01-23 Upgrade BofA Securities Underperform → Neutral
Apr-26-23 Resumed Canaccord Genuity Buy
Jan-06-23 Downgrade BofA Securities Buy → Underperform
Oct-24-22 Upgrade SVB Leerink Mkt Perform → Outperform
Jan-31-22 Initiated Jefferies Buy
Dec-03-21 Initiated BofA Securities Buy
Nov-22-21 Upgrade JP Morgan Neutral → Overweight
May-18-21 Initiated UBS Neutral
May-10-21 Upgrade Wedbush Neutral → Outperform
Apr-26-21 Resumed Credit Suisse Outperform
Feb-10-21 Downgrade Wedbush Outperform → Neutral
Dec-15-20 Resumed H.C. Wainwright Buy
Dec-11-20 Reiterated Needham Buy
Oct-23-20 Initiated Cantor Fitzgerald Overweight
Sep-29-20 Resumed JP Morgan Neutral
Sep-29-20 Initiated Needham Buy
Dec-18-19 Initiated Wedbush Outperform
Nov-12-19 Initiated BTIG Research Buy
Oct-25-19 Initiated H.C. Wainwright Buy
Jul-15-19 Initiated Canaccord Genuity Buy
Jul-15-19 Initiated Cowen Outperform
Jul-15-19 Initiated Credit Suisse Outperform
Jul-15-19 Initiated JP Morgan Overweight
View All

Stoke Therapeutics Inc Stock (STOK) Latest News

pulisher
12:35 PM

What are Stoke Therapeutics Inc. company’s key revenue driversExpert Picks Target Finder For Consistent Profits - jammulinksnews.com

12:35 PM
pulisher
Jul 31, 2025

Real time breakdown of Stoke Therapeutics Inc. stock performanceAI Trading Suggestions With Accuracy Focus Released - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Combining machine learning predictions for Stoke Therapeutics Inc.Free Sector Based Breakout Stock Forecast - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Bullish Candlestick Pattern Forms in Stoke Therapeutics Inc.Sector Based Breakout Stock Forecast Issued - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Multi asset correlation models including Stoke Therapeutics Inc.Entry Zone Forecast for Momentum Trading - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Price Channel Expanding on Stoke Therapeutics Inc.’s ChartTrade Setups With AI Powered Filters Published - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What moving averages say about Stoke Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 08:55:21 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

When is Stoke Therapeutics Inc. stock expected to show significant growthPost Market Picks With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Stoke Therapeutics Inc. a growth stock or a value stockGet timely alerts on market movers - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Stoke Therapeutics Inc. stock price move sharplyInvest confidently with actionable market data - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Stoke Therapeutics Inc. Stock a Good Fit for Conservative Investors Technical Screener for High Growth Stocks - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Stoke Therapeutics Inc. stockExpert guidance for superior capital growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Stoke Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPredictable High Return Trades - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Stoke Therapeutics Inc. stock in 2025Earnings Report Alerts For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Stoke Therapeutics Inc. company’s balance sheetUnlock exclusive investment alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Stoke Therapeutics Inc. stock compared to the marketSuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Stoke Therapeutics Inc. in the next 12 monthsDiscover market opportunities others miss - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Stoke Therapeutics Inc. generate profit in a changing economyInvest smarter with actionable market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Stoke Therapeutics Inc. compare to its industry peersBuild wealth with steady, reliable stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Stoke Therapeutics Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Stoke Therapeutics Inc. a good long term investmentSuperior return velocity - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Stoke Therapeutics Inc. stockExtraordinary market timing - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Bets Big On Rare Disease Therapies - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Soars 17.02% on Market Optimism - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Stoke Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Stoke Therapeutics Inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 15:57:09 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 13:02:52 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Jefferies Financial Group Begins Coverage on Stoke Therapeutics (NASDAQ:STOK) - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com

Jul 20, 2025

Stoke Therapeutics Inc Stock (STOK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.68
price up icon 0.43%
$36.84
price up icon 0.14%
$26.18
price down icon 0.64%
$106.89
price up icon 0.17%
$105.83
price down icon 1.59%
biotechnology ONC
$290.19
price down icon 3.72%
Cap:     |  Volume (24h):